Market capitalization | GBP1.24b |
Enterprise Value | GBP2.81b |
P/E (TTM) P/E ratio | 17.69 |
EV/FCF (TTM) EV/FCF | 32.17 |
EV/Sales (TTM) EV/Sales | 16.92 |
P/S ratio (TTM) P/S ratio | 7.44 |
P/B ratio (TTM) P/B ratio | 0.77 |
Dividend yield | 8.62% |
Last dividend (FY24) | GBP0.03 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
10 Analysts have issued a Assura forecast:
10 Analysts have issued a Assura forecast:
Sep '24 |
+/-
%
|
||
Revenue | 166 166 |
7%
7%
|
|
Gross Profit | 151 151 |
7%
7%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 137 137 |
7%
7%
|
Net Profit | 66 66 |
139%
139%
|
In millions GBP.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Assura Plc is a healthcare real estate investment trust, which engages in the provision of property solutions. It works with general practitioner, health professionals, and National Health Service, and invests and develops property for the healthcare sector. The company was founded in 2003 and is headquartered in Warrington, United Kingdom.
Head office | United Kingdom |
CEO | Jonathan Murphy |
Employees | 84 |
Founded | 2003 |
Website | assura.co.uk |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.